HEADER HYDROLASE 10-JUL-03 1OJJ TITLE ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA TITLE 2 INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOGLUCANASE I; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENDO-1,4-BETA-GLUCANASE; COMPND 5 EC: 3.2.1.4; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMICOLA INSOLENS; SOURCE 3 ORGANISM_TAXID: 34413; SOURCE 4 EXPRESSION_SYSTEM: ASPERGILLUS ORYZAE; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 5062 KEYWDS HYDROLASE, CELLULOSE DEGRADATION, GLYCOSYNTHASE EXPDTA X-RAY DIFFRACTION AUTHOR V.M.-A.DUCROS,C.A.TARLING,D.L.ZECHEL,A.M.BRZOZOWSKI,T.P.FRANDSEN, AUTHOR 2 I.VON OSSOWSKI,M.SCHULEIN,S.G.WITHERS,G.J.DAVIES REVDAT 8 06-NOV-24 1OJJ 1 REMARK REVDAT 7 13-DEC-23 1OJJ 1 HETSYN LINK REVDAT 6 29-JUL-20 1OJJ 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 11-MAR-20 1OJJ 1 SEQRES REVDAT 4 08-MAY-19 1OJJ 1 REMARK LINK REVDAT 3 24-FEB-09 1OJJ 1 VERSN REVDAT 2 14-JAN-04 1OJJ 1 AUTHOR JRNL REVDAT 1 07-JAN-04 1OJJ 0 JRNL AUTH V.M.-A.DUCROS,C.A.TARLING,D.L.ZECHEL,A.M.BRZOZOWSKI, JRNL AUTH 2 T.P.FRANDSEN,I.VON OSSOWSKI,M.SCHULEIN,S.G.WITHERS, JRNL AUTH 3 G.J.DAVIES JRNL TITL ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE JRNL TITL 2 HUMICOLA INSOLENS CEL7B E197A AND E197S GLYCOSYNTHASE JRNL TITL 3 MUTANTS JRNL REF CHEM.BIOL. V. 10 619 2003 JRNL REFN ISSN 1074-5521 JRNL PMID 12890535 JRNL DOI 10.1016/S1074-5521(03)00143-1 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 149738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.173 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7945 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 10236 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1570 REMARK 3 BIN FREE R VALUE SET COUNT : 517 REMARK 3 BIN FREE R VALUE : 0.2060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6170 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 642 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : -0.31000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.053 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.029 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.543 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6530 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 5579 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8873 ; 1.569 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13057 ; 0.848 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 794 ; 6.234 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 299 ;31.314 ;24.181 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1040 ;12.129 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;17.231 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 942 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7228 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1302 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1110 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5477 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3415 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 358 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.211 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 56 ; 0.179 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.208 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5084 ; 1.426 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1638 ; 0.472 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6357 ; 1.664 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3055 ; 2.602 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2516 ; 3.398 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1OJJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1290012650. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 157771 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 35.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DYM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROPS 20MM TRIS-HCL PH7-8.5, REMARK 280 280 15-30% POLYETHYLENE GLYCOL 4000, PH 7.00, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.37300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE GLU 197 SER REMARK 400 REMARK 400 N-LINKED N-ACETYLGLUCOSAMINE ON RESIDUE ASN 247, REMARK 400 PYROGLUTAMATE POST-TRANSLATIONAL MODIFICATION ON REMARK 400 RESIDUE 1 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 400 REMARK 465 LEU A 401 REMARK 465 GLN A 402 REMARK 465 GLU B 400 REMARK 465 LEU B 401 REMARK 465 GLN B 402 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 399 CA C O CB CG CD OE1 REMARK 470 GLN A 399 NE2 REMARK 470 GLN B 399 CA C O CB CG CD OE1 REMARK 470 GLN B 399 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 159 OE2 GLU A 316 2555 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 104 75.82 -119.78 REMARK 500 LYS A 137 30.54 -94.83 REMARK 500 CYS A 140 135.16 -39.73 REMARK 500 ASN A 300 38.81 -143.95 REMARK 500 ALA A 328 -166.64 62.52 REMARK 500 ASP A 358 13.06 -143.86 REMARK 500 VAL B 104 78.07 -117.71 REMARK 500 LYS B 116 -0.29 68.99 REMARK 500 LYS B 137 31.07 -96.30 REMARK 500 ASN B 300 49.29 -145.84 REMARK 500 ALA B 328 -164.63 61.35 REMARK 500 ASP B 358 12.85 -141.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A39 RELATED DB: PDB REMARK 900 HUMICOLA INSOLENS ENDOCELLULASE EGI S37W, P39W DOUBLE-MUTANT REMARK 900 RELATED ID: 1DYM RELATED DB: PDB REMARK 900 HUMICOLA INSOLENS ENDOCELLULASE CEL7B (EG 1) E197A MUTANT REMARK 900 RELATED ID: 1OJI RELATED DB: PDB REMARK 900 ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA REMARK 900 INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS REMARK 900 RELATED ID: 1OJK RELATED DB: PDB REMARK 900 ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA REMARK 900 INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS REMARK 900 RELATED ID: 2A39 RELATED DB: PDB REMARK 900 HUMICOLA INSOLENS ENDOCELLULASE EGI NATIVE STRUCTURE REMARK 999 REMARK 999 SEQUENCE REMARK 999 PYROGLUTAMATE REMARK 999 POST-TRANSLATIONAL MODIFICATION AT RESIDUE 1, REMARK 999 MUTATION E197S, REMARK 999 MISSING LAST FOUR RESIDUES. DBREF 1OJJ A 1 402 UNP P56680 GUN1_HUMIN 1 402 DBREF 1OJJ B 1 402 UNP P56680 GUN1_HUMIN 1 402 SEQADV 1OJJ SER A 197 UNP P56680 GLU 197 ENGINEERED MUTATION SEQADV 1OJJ SER B 197 UNP P56680 GLU 197 ENGINEERED MUTATION SEQRES 1 A 402 PCA LYS PRO GLY GLU THR LYS GLU VAL HIS PRO GLN LEU SEQRES 2 A 402 THR THR PHE ARG CYS THR LYS ARG GLY GLY CYS LYS PRO SEQRES 3 A 402 ALA THR ASN PHE ILE VAL LEU ASP SER LEU SER HIS PRO SEQRES 4 A 402 ILE HIS ARG ALA GLU GLY LEU GLY PRO GLY GLY CYS GLY SEQRES 5 A 402 ASP TRP GLY ASN PRO PRO PRO LYS ASP VAL CYS PRO ASP SEQRES 6 A 402 VAL GLU SER CYS ALA LYS ASN CYS ILE MET GLU GLY ILE SEQRES 7 A 402 PRO ASP TYR SER GLN TYR GLY VAL THR THR ASN GLY THR SEQRES 8 A 402 SER LEU ARG LEU GLN HIS ILE LEU PRO ASP GLY ARG VAL SEQRES 9 A 402 PRO SER PRO ARG VAL TYR LEU LEU ASP LYS THR LYS ARG SEQRES 10 A 402 ARG TYR GLU MET LEU HIS LEU THR GLY PHE GLU PHE THR SEQRES 11 A 402 PHE ASP VAL ASP ALA THR LYS LEU PRO CYS GLY MET ASN SEQRES 12 A 402 SER ALA LEU TYR LEU SER GLU MET HIS PRO THR GLY ALA SEQRES 13 A 402 LYS SER LYS TYR ASN PRO GLY GLY ALA TYR TYR GLY THR SEQRES 14 A 402 GLY TYR CYS ASP ALA GLN CYS PHE VAL THR PRO PHE ILE SEQRES 15 A 402 ASN GLY LEU GLY ASN ILE GLU GLY LYS GLY SER CYS CYS SEQRES 16 A 402 ASN SER MET ASP ILE TRP GLU ALA ASN SER ARG ALA SER SEQRES 17 A 402 HIS VAL ALA PRO HIS THR CYS ASN LYS LYS GLY LEU TYR SEQRES 18 A 402 LEU CYS GLU GLY GLU GLU CYS ALA PHE GLU GLY VAL CYS SEQRES 19 A 402 ASP LYS ASN GLY CYS GLY TRP ASN ASN TYR ARG VAL ASN SEQRES 20 A 402 VAL THR ASP TYR TYR GLY ARG GLY GLU GLU PHE LYS VAL SEQRES 21 A 402 ASN THR LEU LYS PRO PHE THR VAL VAL THR GLN PHE LEU SEQRES 22 A 402 ALA ASN ARG ARG GLY LYS LEU GLU LYS ILE HIS ARG PHE SEQRES 23 A 402 TYR VAL GLN ASP GLY LYS VAL ILE GLU SER PHE TYR THR SEQRES 24 A 402 ASN LYS GLU GLY VAL PRO TYR THR ASN MET ILE ASP ASP SEQRES 25 A 402 GLU PHE CYS GLU ALA THR GLY SER ARG LYS TYR MET GLU SEQRES 26 A 402 LEU GLY ALA THR GLN GLY MET GLY GLU ALA LEU THR ARG SEQRES 27 A 402 GLY MET VAL LEU ALA MET SER ILE TRP TRP ASP GLN GLY SEQRES 28 A 402 GLY ASN MET GLU TRP LEU ASP HIS GLY GLU ALA GLY PRO SEQRES 29 A 402 CYS ALA LYS GLY GLU GLY ALA PRO SER ASN ILE VAL GLN SEQRES 30 A 402 VAL GLU PRO PHE PRO GLU VAL THR TYR THR ASN LEU ARG SEQRES 31 A 402 TRP GLY GLU ILE GLY SER THR TYR GLN GLU LEU GLN SEQRES 1 B 402 PCA LYS PRO GLY GLU THR LYS GLU VAL HIS PRO GLN LEU SEQRES 2 B 402 THR THR PHE ARG CYS THR LYS ARG GLY GLY CYS LYS PRO SEQRES 3 B 402 ALA THR ASN PHE ILE VAL LEU ASP SER LEU SER HIS PRO SEQRES 4 B 402 ILE HIS ARG ALA GLU GLY LEU GLY PRO GLY GLY CYS GLY SEQRES 5 B 402 ASP TRP GLY ASN PRO PRO PRO LYS ASP VAL CYS PRO ASP SEQRES 6 B 402 VAL GLU SER CYS ALA LYS ASN CYS ILE MET GLU GLY ILE SEQRES 7 B 402 PRO ASP TYR SER GLN TYR GLY VAL THR THR ASN GLY THR SEQRES 8 B 402 SER LEU ARG LEU GLN HIS ILE LEU PRO ASP GLY ARG VAL SEQRES 9 B 402 PRO SER PRO ARG VAL TYR LEU LEU ASP LYS THR LYS ARG SEQRES 10 B 402 ARG TYR GLU MET LEU HIS LEU THR GLY PHE GLU PHE THR SEQRES 11 B 402 PHE ASP VAL ASP ALA THR LYS LEU PRO CYS GLY MET ASN SEQRES 12 B 402 SER ALA LEU TYR LEU SER GLU MET HIS PRO THR GLY ALA SEQRES 13 B 402 LYS SER LYS TYR ASN PRO GLY GLY ALA TYR TYR GLY THR SEQRES 14 B 402 GLY TYR CYS ASP ALA GLN CYS PHE VAL THR PRO PHE ILE SEQRES 15 B 402 ASN GLY LEU GLY ASN ILE GLU GLY LYS GLY SER CYS CYS SEQRES 16 B 402 ASN SER MET ASP ILE TRP GLU ALA ASN SER ARG ALA SER SEQRES 17 B 402 HIS VAL ALA PRO HIS THR CYS ASN LYS LYS GLY LEU TYR SEQRES 18 B 402 LEU CYS GLU GLY GLU GLU CYS ALA PHE GLU GLY VAL CYS SEQRES 19 B 402 ASP LYS ASN GLY CYS GLY TRP ASN ASN TYR ARG VAL ASN SEQRES 20 B 402 VAL THR ASP TYR TYR GLY ARG GLY GLU GLU PHE LYS VAL SEQRES 21 B 402 ASN THR LEU LYS PRO PHE THR VAL VAL THR GLN PHE LEU SEQRES 22 B 402 ALA ASN ARG ARG GLY LYS LEU GLU LYS ILE HIS ARG PHE SEQRES 23 B 402 TYR VAL GLN ASP GLY LYS VAL ILE GLU SER PHE TYR THR SEQRES 24 B 402 ASN LYS GLU GLY VAL PRO TYR THR ASN MET ILE ASP ASP SEQRES 25 B 402 GLU PHE CYS GLU ALA THR GLY SER ARG LYS TYR MET GLU SEQRES 26 B 402 LEU GLY ALA THR GLN GLY MET GLY GLU ALA LEU THR ARG SEQRES 27 B 402 GLY MET VAL LEU ALA MET SER ILE TRP TRP ASP GLN GLY SEQRES 28 B 402 GLY ASN MET GLU TRP LEU ASP HIS GLY GLU ALA GLY PRO SEQRES 29 B 402 CYS ALA LYS GLY GLU GLY ALA PRO SER ASN ILE VAL GLN SEQRES 30 B 402 VAL GLU PRO PHE PRO GLU VAL THR TYR THR ASN LEU ARG SEQRES 31 B 402 TRP GLY GLU ILE GLY SER THR TYR GLN GLU LEU GLN MODRES 1OJJ ASN A 247 ASN GLYCOSYLATION SITE MODRES 1OJJ ASN B 247 ASN GLYCOSYLATION SITE MODRES 1OJJ PCA A 1 GLU PYROGLUTAMIC ACID MODRES 1OJJ PCA B 1 GLU PYROGLUTAMIC ACID HET PCA A 1 8 HET PCA B 1 8 HET BGC C 1 12 HET GAL C 2 11 HET GLC D 1 12 HET GAL D 2 11 HET BGC E 1 12 HET GAL E 2 11 HET GLC F 1 12 HET GAL F 2 11 HET NAG A1404 14 HET NAG B1399 14 HETNAM PCA PYROGLUTAMIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 PCA 2(C5 H7 N O3) FORMUL 3 BGC 2(C6 H12 O6) FORMUL 3 GAL 4(C6 H12 O6) FORMUL 4 GLC 2(C6 H12 O6) FORMUL 7 NAG 2(C8 H15 N O6) FORMUL 9 HOH *642(H2 O) HELIX 1 1 SER A 35 HIS A 38 5 4 HELIX 2 2 ASP A 65 ASN A 72 1 8 HELIX 3 3 ASP A 80 TYR A 84 5 5 HELIX 4 4 GLY A 163 GLY A 168 5 6 HELIX 5 5 GLU A 224 ALA A 229 5 6 HELIX 6 6 ASN A 242 ASN A 247 5 6 HELIX 7 7 ASP A 311 THR A 318 1 8 HELIX 8 8 SER A 320 LEU A 326 1 7 HELIX 9 9 GLY A 327 GLY A 339 1 13 HELIX 10 10 MET A 354 HIS A 359 1 6 HELIX 11 11 GLY A 360 GLY A 363 5 4 HELIX 12 12 ALA A 371 GLU A 379 1 9 HELIX 13 13 SER B 35 HIS B 38 5 4 HELIX 14 14 ASP B 65 ASN B 72 1 8 HELIX 15 15 ASP B 80 TYR B 84 5 5 HELIX 16 16 GLY B 163 GLY B 168 5 6 HELIX 17 17 GLU B 224 ALA B 229 5 6 HELIX 18 18 ASN B 242 ASN B 247 5 6 HELIX 19 19 ASP B 311 THR B 318 1 8 HELIX 20 20 SER B 320 LEU B 326 1 7 HELIX 21 21 GLY B 327 GLY B 339 1 13 HELIX 22 22 MET B 354 HIS B 359 1 6 HELIX 23 23 GLY B 360 GLY B 363 5 4 HELIX 24 24 ALA B 371 GLU B 379 1 9 SHEET 1 AA 7 VAL A 86 ASN A 89 0 SHEET 2 AA 7 SER A 92 GLN A 96 -1 O SER A 92 N ASN A 89 SHEET 3 AA 7 GLU A 383 GLY A 392 -1 O VAL A 384 N LEU A 95 SHEET 4 AA 7 GLN A 12 THR A 19 1 O PHE A 16 N TRP A 391 SHEET 5 AA 7 GLY A 23 LEU A 33 -1 O GLY A 23 N THR A 19 SHEET 6 AA 7 ARG A 108 LEU A 112 -1 O TYR A 110 N VAL A 32 SHEET 7 AA 7 MET A 340 TRP A 347 -1 O LEU A 342 N LEU A 111 SHEET 1 AB 7 VAL A 86 ASN A 89 0 SHEET 2 AB 7 SER A 92 GLN A 96 -1 O SER A 92 N ASN A 89 SHEET 3 AB 7 GLU A 383 GLY A 392 -1 O VAL A 384 N LEU A 95 SHEET 4 AB 7 GLU A 128 ASP A 134 -1 O GLU A 128 N GLY A 392 SHEET 5 AB 7 PHE A 266 ALA A 274 -1 O PHE A 266 N VAL A 133 SHEET 6 AB 7 LEU A 280 GLN A 289 -1 N GLU A 281 O LEU A 273 SHEET 7 AB 7 LYS A 292 ILE A 294 -1 O LYS A 292 N GLN A 289 SHEET 1 AC 2 ILE A 40 ARG A 42 0 SHEET 2 AC 2 CYS A 73 MET A 75 -1 O ILE A 74 N HIS A 41 SHEET 1 AD 3 PHE A 177 VAL A 178 0 SHEET 2 AD 3 GLY A 192 CYS A 194 -1 N SER A 193 O PHE A 177 SHEET 3 AD 3 TYR A 221 CYS A 223 -1 O TYR A 221 N CYS A 194 SHEET 1 AE 2 PHE A 181 ILE A 182 0 SHEET 2 AE 2 LEU A 185 GLY A 186 -1 O LEU A 185 N ILE A 182 SHEET 1 AF 2 TYR A 252 GLY A 253 0 SHEET 2 AF 2 VAL A 260 ASN A 261 1 O VAL A 260 N GLY A 253 SHEET 1 BA10 VAL B 86 ASN B 89 0 SHEET 2 BA10 SER B 92 GLN B 96 -1 O SER B 92 N ASN B 89 SHEET 3 BA10 GLU B 383 GLY B 392 -1 O VAL B 384 N LEU B 95 SHEET 4 BA10 GLN B 12 THR B 19 1 O PHE B 16 N TRP B 391 SHEET 5 BA10 GLY B 23 LEU B 33 -1 O GLY B 23 N THR B 19 SHEET 6 BA10 ARG B 108 LEU B 112 -1 O TYR B 110 N VAL B 32 SHEET 7 BA10 VAL B 341 TRP B 347 -1 O LEU B 342 N LEU B 111 SHEET 8 BA10 ASN B 143 SER B 149 -1 O ASN B 143 N TRP B 347 SHEET 9 BA10 SER B 197 ALA B 203 -1 O MET B 198 N LEU B 148 SHEET 10 BA10 SER B 208 HIS B 213 -1 O HIS B 209 N GLU B 202 SHEET 1 BB 7 VAL B 86 ASN B 89 0 SHEET 2 BB 7 SER B 92 GLN B 96 -1 O SER B 92 N ASN B 89 SHEET 3 BB 7 GLU B 383 GLY B 392 -1 O VAL B 384 N LEU B 95 SHEET 4 BB 7 GLU B 128 ASP B 134 -1 O GLU B 128 N GLY B 392 SHEET 5 BB 7 PHE B 266 ALA B 274 -1 O PHE B 266 N VAL B 133 SHEET 6 BB 7 LEU B 280 GLN B 289 -1 N GLU B 281 O LEU B 273 SHEET 7 BB 7 LYS B 292 ILE B 294 -1 O LYS B 292 N GLN B 289 SHEET 1 BC 2 ILE B 40 ARG B 42 0 SHEET 2 BC 2 CYS B 73 MET B 75 -1 O ILE B 74 N HIS B 41 SHEET 1 BD 3 PHE B 177 VAL B 178 0 SHEET 2 BD 3 GLY B 192 CYS B 194 -1 N SER B 193 O PHE B 177 SHEET 3 BD 3 TYR B 221 CYS B 223 -1 O TYR B 221 N CYS B 194 SHEET 1 BE 2 PHE B 181 ILE B 182 0 SHEET 2 BE 2 LEU B 185 GLY B 186 -1 O LEU B 185 N ILE B 182 SHEET 1 BF 2 TYR B 252 GLY B 253 0 SHEET 2 BF 2 VAL B 260 ASN B 261 1 O VAL B 260 N GLY B 253 SSBOND 1 CYS A 18 CYS A 24 1555 1555 2.11 SSBOND 2 CYS A 51 CYS A 73 1555 1555 2.03 SSBOND 3 CYS A 63 CYS A 69 1555 1555 2.09 SSBOND 4 CYS A 140 CYS A 365 1555 1555 2.05 SSBOND 5 CYS A 172 CYS A 195 1555 1555 2.06 SSBOND 6 CYS A 176 CYS A 194 1555 1555 2.06 SSBOND 7 CYS A 215 CYS A 234 1555 1555 2.02 SSBOND 8 CYS A 223 CYS A 228 1555 1555 2.07 SSBOND 9 CYS A 239 CYS A 315 1555 1555 2.04 SSBOND 10 CYS B 18 CYS B 24 1555 1555 2.08 SSBOND 11 CYS B 51 CYS B 73 1555 1555 2.02 SSBOND 12 CYS B 63 CYS B 69 1555 1555 2.07 SSBOND 13 CYS B 140 CYS B 365 1555 1555 2.06 SSBOND 14 CYS B 172 CYS B 195 1555 1555 2.02 SSBOND 15 CYS B 176 CYS B 194 1555 1555 2.03 SSBOND 16 CYS B 215 CYS B 234 1555 1555 2.04 SSBOND 17 CYS B 223 CYS B 228 1555 1555 2.05 SSBOND 18 CYS B 239 CYS B 315 1555 1555 2.03 LINK C PCA A 1 N LYS A 2 1555 1555 1.33 LINK ND2 ASN A 247 C1 NAG A1404 1555 1555 1.46 LINK C PCA B 1 N LYS B 2 1555 1555 1.33 LINK ND2 ASN B 247 C1 NAG B1399 1555 1555 1.44 LINK O4 BGC C 1 C1 GAL C 2 1555 1555 1.44 LINK O4 GLC D 1 C1 GAL D 2 1555 1555 1.42 LINK O4 BGC E 1 C1 GAL E 2 1555 1555 1.43 LINK O4 GLC F 1 C1 GAL F 2 1555 1555 1.43 CRYST1 66.364 74.746 85.820 90.00 102.51 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015068 0.000000 0.003343 0.00000 SCALE2 0.000000 0.013379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011936 0.00000 MTRIX1 1 0.999440 -0.031900 -0.010070 23.90932 1 MTRIX2 1 0.032340 0.998350 0.047440 0.50131 1 MTRIX3 1 0.008540 -0.047740 0.998820 42.00525 1 HETATM 1 N PCA A 1 -2.324 11.816 6.041 1.00 11.43 N ANISOU 1 N PCA A 1 1547 1280 1514 28 -98 -81 N HETATM 2 CA PCA A 1 -2.698 13.081 6.617 1.00 10.35 C ANISOU 2 CA PCA A 1 1293 1280 1356 22 61 -8 C HETATM 3 CB PCA A 1 -1.937 13.209 7.924 1.00 10.47 C ANISOU 3 CB PCA A 1 1383 1298 1296 -8 86 -100 C HETATM 4 CG PCA A 1 -0.812 12.190 7.897 1.00 10.31 C ANISOU 4 CG PCA A 1 1322 1242 1351 -13 90 9 C HETATM 5 CD PCA A 1 -1.178 11.333 6.718 1.00 11.01 C ANISOU 5 CD PCA A 1 1482 1274 1428 -34 38 -8 C HETATM 6 OE PCA A 1 -0.605 10.318 6.318 1.00 12.53 O ANISOU 6 OE PCA A 1 1717 1388 1655 155 -66 -157 O HETATM 7 C PCA A 1 -2.485 14.226 5.641 1.00 10.43 C ANISOU 7 C PCA A 1 1306 1332 1324 -13 72 6 C HETATM 8 O PCA A 1 -1.660 14.155 4.749 1.00 11.92 O ANISOU 8 O PCA A 1 1486 1458 1583 18 142 -28 O